Specific and non-specific phagocytosis of ligand-grafted PLGA microspheres by macrophages

European Journal of Pharmaceutical Sciences

Volumn 36, Issue 4-5, 2009, Pages 474-485

  Brandhonneur, Nolwenn ^a,e   Chevanne, François ^a   Vié, Véronique ^b   Frisch, Benoît ^c   Primault, Roselyne ^d   Le Potier, Marie Frédérique ^e   Le Corre, Pascal ^a  

^a UPRES EA 3892   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d Lab de Microbiologie Pharmaceutique   (France)

^e Healthy Pigs Production and Experimentation Section   (France)

Author keywords

Functionalization; Ligands; Macrophages; Phagocytosis; PLGA microspheres

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; CARBOHYDRATE DERIVATIVE; CATION; CYTOCHALASIN D; MANNOSE; MICROSPHERE; POLYGLACTIN; WHEAT GERM AGGLUTININ;

ANIMAL CELL; ARTICLE; ATOMIC FORCE MICROSCOPY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; COVALENT BOND; LIGAND BINDING; LUNG ALVEOLUS MACROPHAGE; MATHEMATICAL ANALYSIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPRAY DRYING;

LACTIC ACID; LIGANDS; MACROPHAGES; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PHAGOCYTOSIS; POLYGLYCOLIC ACID;

EID: 59549086741     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2008.11.013     Document Type: Article

References (53)

1. Bar G., Thomann Y., and Whangbo M.H. Characterization of the morphologies and nanostructures of blends of poly(styrene)-block-poly(ethene-co-but-1-ene)-block-poly(styrene) with isotactic and atactic polypropylenes by tapping-mode atomic force microscopy. Langmuir 14 (1998) 1219-1226
2. Baron T., Albina E., Leforban Y., Madec F., Guilmoto H., Plana Duran J., and Vannier P. Report on the first outbreaks of the porcine reproductive and respiratory syndrome (PRRS) in France. Diagnosis and viral isolation. Ann. Rech. Vet. 23 (1992) 161-166
3. Byrd W., and Cassels F.J. Intranasal immunization of BALB/c mice with enterotoxigenic Escherichia coli colonization factor CS6 encapsulated in biodegradable poly(dl-lactide-co-glycolide) microspheres. Vaccine 24 (2006) 1359-1366
4. Camner P., Lundborg M., Lastbom L., Gerde P., Gross N., and Jarstrand C. Experimental and calculated parameters on particle phagocytosis by alveolar macrophages. J. Appl. Physiol. 92 (2002) 2608-2616
5. Carr K.E., Hazzard R.A., Reid S., and Hodges G.M. The effect of size on uptake of orally administered latex microparticles in the small intestine and transport to mesenteric lymph nodes. Pharm. Res. 13 (1996) 1205-1209
6. Chavanpatil M.D., Khdair A., and Panyam J. Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery. J. Nanosci. Nanotechnol. 6 (2006) 2651-2663
7. Conner S.D., and Schmid S.L. Regulated portals of entry into the cell. Nature 422 (2003) 37-44
8. Cui Z., Hsu C.H., and Mumper R.J. Physical characterization and macrophage cell uptake of mannan-coated nanoparticles. Drug Dev. Ind. Pharm. 29 (2003) 689-700
9. Cui Z., Han S.J., and Huang L. Coating of mannan on LPD particles containing HPV E7 peptide significantly enhances immunity against HPV-positive tumor. Pharm. Res. 21 (2004) 1018-1025
10. Davis S.S. The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery. Vaccine 24 Suppl. 2 (2006) S7-S10
11. Dawson G.F., and Halbert G.W. The in vitro cell association of invasin coated polylactide-co-glycolide nanoparticles. Pharm. Res. 17 (2000) 1420-1425
12. Desai M.P., Labhasetwar V., Walter E., Levy R.J., and Amidon G.L. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res. 14 (1997) 1568-1573
13. Dubreil L., Vie V., Beaufils S., Marion D., and Renault A. Aggregation of puroindoline in phospholipid monolayers spread at the air-liquid interface. Biophys. J. 85 (2003) 2650-2660
14. Faraasen S., Voros J., Csucs G., Textor M., Merkle H.P., and Walter E. Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(l-lysine)-grafted poly(ethylene glycol) conjugate. Pharm. Res. 20 (2003) 237-246
15. Gabrielsson J., and Weiner D. Pharmacodynamic concepts. Swedish Pharmaceutical Society (Apotekarsocieteten), Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications (1997), Swedish Pharmaceutical Press, Stockholm pp. 172-250
16. Garinot M., Fievez V., Pourcelle V., Stoffelbach F., Des Rieux A., Plapied L., Theate I., Freichels H., Jerome C., Marchand-Brynaert J., Schneider Y.J., and Preat V. PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. J. Control. Rel. 120 (2007) 195-204
17. Gullberg E., Keita A.V., Salim S.Y., Andersson M., Caldwell K.D., Soderholm J.D., and Artursson P. Identification of cell adhesion molecules in the human follicle-associated epithelium that improve nanoparticle uptake into the Peyer's patches. J. Pharmacol. Exp. Ther. 319 (2006) 632-639
18. Hirota K., Hasegawa T., Hinata H., Ito F., Inagawa H., Kochi C., Soma G., Makino K., and Terada H. Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages. J. Control. Rel. 119 (2007) 69-76
19. Hussain N., and Florence A.T. Utilizing bacterial mechanisms of epithelial cell entry: invasin-induced oral uptake of latex nanoparticles. Pharm. Res. 15 (1998) 153-156
20. Jaganathan K.S., and Vyas S.P. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine 24 (2006) 4201-4211
21. Jain R.A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 21 (2000) 2475-2490
22. Jain S., and Vyas S.P. Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization. J. Liposome Res. 16 (2006) 331-345
23. Jones B.G., Dickinson P.A., Gumbleton M., and Kellaway I.W. The inhibition of phagocytosis of respirable microspheres by alveolar and peritoneal macrophages. Int. J. Pharm. 236 (2002) 65-79
24. Le Corre P., Estebe J.P., Clement R., Du Plessis L., Chevanne F., Ecoffey C., and Le Verge R. Spray-dryed bupivacaine-loaded microspheres: in vitro evaluation and biopharmaceutics of bupivacaine following brachial plexus administration in sheep. Int. J. Pharm. 238 (2002) 191-203
25. Lee S.K., and Row K.H. Optimum separation condition of peptides in reversed-phase liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 800 (2004) 115-120
26. Mackie A.R., Gunning A.P., Wilde P.J., and Morris V.J. Orogenic displacement of protein from the air/water interface by competitive adsorption. J. Colloids Interface Sci. 210 (1999) 157-166
27. Martinez N.F., and Garcia R. Measuring phase shifts and energy dissipation with amplitude modulation atomic force microscopy. Nanotechnology 17 (2006) S167-S172
28. Mo Y., and Lim L.Y. Mechanistic study of the uptake of wheat germ agglutinin-conjugated PLGA nanoparticles by A549 cells. J. Pharm. Sci. 93 (2004) 20-28
29. Mo Y., and Lim L.Y. Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. J. Control. Rel. 108 (2005) 244-262
30. Monsigny M., Petit C., and Roche A.C. Colorimetric determination of neutral sugars by a resorcinol sulfuric acid micromethod. Anal. Biochem. 175 (1988) 525-530
31. Mu L., and Feng S.S. Fabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly(lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers. J. Control. Rel. 76 (2001) 239-254
32. Mutwiri G., Bowersock T.L., and Babiuk L.A. Microparticles for oral delivery of vaccines. Expert Opin. Drug Deliv. 2 (2005) 791-806
33. Niborski V., Li Y., Brennan F., Lane M., Torche A.M., Remond M., Bonneau M., Riffault S., Stirling C., Hutchings G., Takamatsu H., Barnett P., Charley B., and Schwartz-Cornil I. Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV. Vaccine 24 (2006) 7204-7213
34. O'hagan D.T., and Singh M. Microparticles as vaccine adjuvants and delivery systems. Expert Rev. Vacc. 2 (2003) 269-283
35. O'hagan D.T., Singh M., and Ulmer J.B. Microparticle-based technologies for vaccines. Methods 40 (2006) 10-19
36. Panyam J., and Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55 (2003) 329-347
37. Reddy S.T., Swartz M.A., and Hubbell J.A. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol. 27 (2006) 573-579
38. Russell-Jones G.J., Veitch H., and Arthur L. Lectin-mediated transport of nanoparticles across Caco-2 and OK cells. Int. J. Pharm. 190 (1999) 165-174
39. Schneider A., Bolcato-Bellemin A.L., Francius G., Jedrzejwska J., Schaaf P., Voegel J.C., Frisch B., and Picart C. Glycated polyelectrolyte multilayer films: differential adhesion of primary versus tumor cells. Biomacromolecules 7 (2006) 2882-2889
40. Sedgmen B.J., Meeusen E.N., and Lofthouse S.A. Alternative routes of mucosal immunization in large animals. Immunol. Cell. Biol. 82 (2004) 10-16
41. Stanley A.C., Buxton D., Innes E.A., and Huntley J.F. Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep. Vaccine 22 (2004) 3929-3941
42. Strindelius L., Filler M., and Sjoholm I. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice. Vaccine 22 (2004) 3797-3808
43. Thiele L., Merkle H.P., and Walter E. Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages. Pharm. Res. 20 (2003) 221-228
44. Thiele L., Rothen-Rutishauser B., Jilek S., Wunderli-Allenspach H., Merkle H.P., and Walter E. Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?. J. Control. Rel. 76 (2001) 59-71
45. Torche A.M., Albina E., Le Corre P., Jestin A., and Le Verge R. Flow cytometric and optical microscopic evaluation of poly(d,l-lactide-co-glycolide) microspheres phagocytosis by pig alveolar macrophages. J. Control. Rel. 58 (1999) 289-301
46. Torche A.M., Le Corre P., Albina E., Jestin A., and Le Verge R. PLGA microspheres phagocytosis by pig alveolar macrophages: influence of poly(vinyl alcohol) concentration, nature of loaded-protein and copolymer nature. J. Drug Target. 7 (2000) 343-354
47. Torche A.M., Le Dimna M., Le Corre P., Mesplede A., Le Gal S., Cariolet R., and Le Potier M.F. Immune responses after local administration of IgY loaded-PLGA microspheres in gut-associated lymphoid tissue in pigs. Vet. Immunol. Immunopathol. 109 (2006) 209-217
48. Vie V., Van Nau N., Lesniewska E., Goudonnet J.P., Heitz F., and Le Grimellec C. Distribution of ganglioside GM1 between two-component, two-phase phosphatidylcholine monolayers. Langmuir 14 (1998) 4574-4583
49. Vyas S.P., and Gupta P.N. Implication of nanoparticles/microparticles in mucosal vaccine delivery. Expert Rev. Vacc. 6 (2007) 401-418
50. Waeckerle-Men Y., and Groettrup M. PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines. Adv. Drug Deliv. Rev. 57 (2005) 475-482
51. Waeckerle-Men Y., Allmen E.U., Gander B., Scandella E., Schlosser E., Schmidtke G., Merkle H.P., and Groettrup M. Encapsulation of proteins and peptides into biodegradable poly(d,l-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells. Vaccine 24 (2006) 1847-1857
52. Weissenboeck A., Bogner E., Wirth M., and Gabor F. Binding and uptake of wheat germ agglutinin-grafted PLGA-nanospheres by caco-2 monolayers. Pharm. Res. 21 (2004) 1917-1923
53. Zhong Q., Inniss D., Kjoller K., and Elings V.B. Fractured polymer/silica fiber surface studied by tapping mode atomic force microscopy. Surf. Sci. Lett. 290 (1993) L688-L692